SG10201802167TA - A method to direct differentiation of pluripotent stem cells into functional heart muscle - Google Patents

A method to direct differentiation of pluripotent stem cells into functional heart muscle

Info

Publication number
SG10201802167TA
SG10201802167TA SG10201802167TA SG10201802167TA SG10201802167TA SG 10201802167T A SG10201802167T A SG 10201802167TA SG 10201802167T A SG10201802167T A SG 10201802167TA SG 10201802167T A SG10201802167T A SG 10201802167TA SG 10201802167T A SG10201802167T A SG 10201802167TA
Authority
SG
Singapore
Prior art keywords
stem cells
pluripotent stem
heart muscle
direct differentiation
functional heart
Prior art date
Application number
SG10201802167TA
Other languages
English (en)
Inventor
Wolfram-Hubertus Zimmermann
James Hudson
Malte Tiburcy
Original Assignee
Repairon Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repairon Gmbh filed Critical Repairon Gmbh
Publication of SG10201802167TA publication Critical patent/SG10201802167TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657Cardiomyocytes; Heart cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/155Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/16Activin; Inhibin; Mullerian inhibiting substance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • C12N2501/415Wnt; Frizzeled
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/72Transferases (EC 2.)
    • C12N2501/727Kinases (EC 2.7.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
SG10201802167TA 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle SG10201802167TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13185344 2013-09-20

Publications (1)

Publication Number Publication Date
SG10201802167TA true SG10201802167TA (en) 2018-04-27

Family

ID=49261445

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10201802167TA SG10201802167TA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle
SG10201910753RA SG10201910753RA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle
SG11201601798RA SG11201601798RA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG10201910753RA SG10201910753RA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle
SG11201601798RA SG11201601798RA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle

Country Status (10)

Country Link
US (3) US10329532B2 (ja)
EP (2) EP3575393A1 (ja)
JP (2) JP6681825B2 (ja)
CN (2) CN105849253B (ja)
AU (1) AU2014323098B2 (ja)
CA (1) CA2924816C (ja)
DK (1) DK3047019T3 (ja)
ES (1) ES2741806T3 (ja)
SG (3) SG10201802167TA (ja)
WO (1) WO2015040142A1 (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015261380B2 (en) 2014-05-16 2021-04-15 Koninklijke Nederlandse Akademie Van Wetenschappen Improved culture method for organoids
US11136551B2 (en) 2015-09-01 2021-10-05 Ncardia B.V. In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population
KR101781693B1 (ko) 2015-09-24 2017-09-26 서울대학교병원 심장내막 유래 성체줄기세포로부터 제조된 유도만능 줄기세포의 심혈관계 세포로의 분화방법 및 이의 용도
GB201603569D0 (en) * 2016-03-01 2016-04-13 Koninklijke Nederlandse Akademie Van Wetenschappen Improved differentiation method
EP3430127A4 (en) * 2016-03-18 2019-09-04 Institute of Biophysics Chinese Academy of Sciences CELL CULTURE MEDIA AND CULTURE MEDIUM SUPPLEMENT
CN106244526B (zh) * 2016-08-23 2020-09-11 北京赛贝生物技术有限公司 心肌分化试剂盒及心肌细胞的培养方法
CN106244527B (zh) * 2016-08-29 2019-10-08 广东依浦赛生物科技有限公司 人源iPS干细胞体外定向分化为心肌细胞的试剂盒及方法
CN110268048B (zh) * 2016-12-04 2024-07-09 大学健康网络 从人多能干细胞生成心房心肌细胞和心室心肌细胞谱系
GB201621594D0 (en) * 2016-12-19 2017-02-01 Univ Leuven Kath Novel cell based methods for healing of bone, cartilage and joint disorders
US20210130785A1 (en) * 2017-01-26 2021-05-06 Osaka University Medium for inducing differentiation of stem cells into mesodermal cells and method for producing mesodermal cells
CN106867961A (zh) * 2017-03-27 2017-06-20 广州润虹医药科技有限公司 一种诱导多能干细胞形成中胚层细胞的诱导培养基及诱导方法
CN108456654A (zh) * 2018-02-22 2018-08-28 上海产业技术研究院 用于促进干细胞来源心肌细胞成熟的无血清培养体系
EP3540046A1 (en) * 2018-03-13 2019-09-18 Medizinische Hochschule Hannover Process for producing cardiac organoids
WO2020012033A1 (en) 2018-07-13 2020-01-16 Lothar Germeroth Non-immunogenic engineered tissue and methods of producing and using the same
CN111214703B (zh) * 2018-11-25 2021-06-15 中国科学院大连化学物理研究所 一种iPS来源心肌细胞复合补片及其制备和应用
CN109619087A (zh) * 2018-11-27 2019-04-16 山东奥博森生物药业股份有限公司 一种小肠黏膜干细胞冻存液及冻存方法
KR20200102329A (ko) * 2019-02-21 2020-08-31 고려대학교 산학협력단 TGFβ1을 이용한 줄기세포를 성숙한 유형별 심근세포로 분화시키는 방법
US11220671B2 (en) 2019-02-21 2022-01-11 Stembiosys, Inc. Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ECM, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds
CN109749986B (zh) * 2019-03-13 2021-04-02 武汉大学 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法
WO2021009070A1 (en) * 2019-07-12 2021-01-21 Genome Biologics Ug Method for generating cardiac tissue mimetics
CN110511904B (zh) * 2019-08-21 2021-03-19 云南中科灵长类生物医学重点实验室 多能干细胞的培养基、培养方法及其应用
EP3835403A1 (en) 2019-12-11 2021-06-16 Sartorius Stedim Biotech GmbH Automated medium exchange strategy for suspension cells
KR102291265B1 (ko) * 2020-03-19 2021-08-18 연세대학교 산학협력단 심장 오가노이드, 이의 제조 방법 및 이를 이용한 약물 독성 평가 방법
CN115427032A (zh) * 2020-03-31 2022-12-02 浙江养生堂天然药物研究所有限公司 药物组合及其用途
EP3945133A1 (en) 2020-07-29 2022-02-02 Georg-August-Universität Göttingen Mass production of human pluripotent stem cell derived cardiac stromal cell
DK3988138T3 (da) 2020-10-22 2024-02-26 Georg August Univ Goettingen Stiftung Oeffentlichen Rechts Univsmedizin Flerlaget kunstig hjertemuskel
CA3200169A1 (en) 2021-01-21 2022-07-28 Luis Haupt Method of changing culture medium of a culture using spinfilters
CA3200171A1 (en) 2021-01-21 2022-07-28 Luis Haupt Application of permittivity measurement probes in an suspension culture aggregate comprising cell aggregates
CN113249310B (zh) * 2021-05-17 2022-10-11 湖北大学 一种拓展性多能干细胞诱导分化为心肌细胞的方法及应用
CN113337459B (zh) * 2021-06-02 2022-09-06 呈诺再生医学科技(珠海横琴新区)有限公司 一种提高多能干细胞分化效能的方法
US20230147883A1 (en) * 2021-11-28 2023-05-11 Fatemeh Etezadi Method for prodcing cardiomyocytes from induced pluripotent stem cells in an integrated process
WO2024008773A1 (en) 2022-07-05 2024-01-11 Repairon Gmbh Differentiation of ipscs in bioreactors
EP4386384A1 (en) 2022-12-15 2024-06-19 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Potency assay for pharmaceutical products

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014209A1 (en) 2002-01-23 2004-01-22 Lassar Andrew B. Compositions and methods for modulating cell differentiation
EP1783206A1 (en) * 2005-11-08 2007-05-09 Universitätsklinikum Hamburg-Eppendorf Multiring engineered heart tissue construct
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
WO2009036982A1 (en) * 2007-07-18 2009-03-26 Cellartis Ab Cardiomyocyte-like cell clusters derived from hbs cells
EP2100954A1 (en) * 2008-03-10 2009-09-16 Assistance Publique - Hopitaux de Paris Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications
WO2010011352A2 (en) 2008-07-25 2010-01-28 The University Of Georgia Research Foundation, Inc. Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use
WO2010144678A2 (en) * 2009-06-10 2010-12-16 The General Hospital Corporation Generation of vascularized human heart tissue and uses thereof
CN101935635A (zh) * 2010-07-30 2011-01-05 中国人民解放军第二军医大学 人骨髓多能干细胞的体外扩增和向多巴胺能神经元定向分化的方法
US9023340B2 (en) * 2011-07-02 2015-05-05 Chemregen, Inc. Wnt inhibitors for human stem cell differentiation
CN103987854A (zh) * 2011-07-21 2014-08-13 小利兰·斯坦福大学托管委员会 来自患者的诱导性多能干细胞的心肌细胞及其使用方法
WO2013056072A1 (en) * 2011-10-13 2013-04-18 Wisconsin Alumni Research Foundation Generation of cardiomyocytes from human pluripotent stem cells
WO2013063305A2 (en) * 2011-10-25 2013-05-02 Mount Sinai School Of Medicine Directed cardiomyocyte differentiation of stem cells
WO2013111875A1 (ja) 2012-01-27 2013-08-01 国立大学法人京都大学 多能性幹細胞の心筋分化誘導法
DK2840132T3 (en) * 2013-08-22 2017-02-20 Georg-August-Universität Göttingen Stiftung Öffenlichen Rechts Universitätsmedizin Method of Manufacturing Constructed Heart Muscle (EHM)

Also Published As

Publication number Publication date
CN105849253B (zh) 2020-10-09
DK3047019T3 (da) 2019-08-26
EP3047019B1 (en) 2019-07-03
JP6681825B2 (ja) 2020-04-15
CA2924816C (en) 2023-09-05
US10329532B2 (en) 2019-06-25
AU2014323098B2 (en) 2020-09-17
US20190300858A1 (en) 2019-10-03
CN105849253A (zh) 2016-08-10
EP3575393A1 (en) 2019-12-04
AU2014323098A1 (en) 2016-05-05
WO2015040142A1 (en) 2015-03-26
SG10201910753RA (en) 2020-01-30
SG11201601798RA (en) 2016-04-28
US20160215264A1 (en) 2016-07-28
ES2741806T3 (es) 2020-02-12
CN112175900A (zh) 2021-01-05
US20190010460A1 (en) 2019-01-10
JP2016536975A (ja) 2016-12-01
EP3047019A1 (en) 2016-07-27
CA2924816A1 (en) 2015-03-26
JP2020115866A (ja) 2020-08-06

Similar Documents

Publication Publication Date Title
SG11201601798RA (en) A method to direct differentiation of pluripotent stem cells into functional heart muscle
EP2808383A4 (en) METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENTER STEM CELLS IN CARDIOMYOCYTES
EP2861612A4 (en) METHODS FOR PREPARING PLURIPOTENT STEM CELLS
EP3234108A4 (en) Differentiation of pluripotent stem cells to form renal organoids
HK1217211A1 (zh) 調節幹細胞的免疫調節作用的方法
SG10201802390XA (en) Methods of differentiating stem cells into one or more cell lineages
IL236672A0 (en) System and methods for preparing vegetable cells from animal fats
HK1208492A1 (en) Highly efficient method for establishing artificial pluripotent stem cell
EP2826855A4 (en) METHOD FOR PRODUCING MIXTURE OF CARDIAC AND VASCULAR CELLS FROM ARTIFICIAL PLURIPOTENT STEM CELLS
PL2741535T3 (pl) Sposób prowadzenia umieszczania nowych małych komórek
EP2968549A4 (en) CELL CULTURE METHODS
EP2794860A4 (en) METHOD OF INDUCING A DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS INTO INTERMEDIATE MESODERM CELLS
EP2971040A4 (en) CELL CULTURE METHODS
EP2971014A4 (en) CELL CULTURE METHODS
GB201223210D0 (en) Method of attaching a dental component to a dental implant
HK1222200A1 (zh) 製備多能幹細胞的方法
EP2900808A4 (en) METHOD FOR DIFFERENTIATING STEM CELLS IN CHONDROCYTES
HK1220487A1 (zh) 全能幹細胞的誘導方法、及用該方法製備的全能幹細胞
EP2912166A4 (en) METHOD FOR THE PRODUCTION OF PLURIPOTENTIAL STEM CELLS FROM CHONDROCYTES
SG11201503167XA (en) Method of efficiently establishing induced pluripotent stem cells
GB2523696B (en) Methods of differentiating stem cells to pancreatic progenitor cells by modulating miR-124
EP2913396A4 (en) METHOD FOR PRODUCING DIFFERENTIATED PLURIPOTENTER STEM CELLS
EP2949746A4 (en) METHOD OF SUB-CULTURE OF PLURIPOTENT STEM CELLS
HK1208249A1 (en) Method of extracting neural stem cells using nanoparticles
EP3050961A4 (en) Method for improving efficiency of inducing pluripotent stem cell